Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seraph Group is a structured angel investment firm that focuses on early-stage investments across various sectors, with a significant emphasis on life sciences, biotechnology, and healthcare. Founded in 2004, the firm operates as a network of over 300 accredited investors who provide capital and expertise to high-growth startups. Seraph Group's portfolio includes numerous companies in the medical device, diagnostic, and therapeutic spaces, leveraging its members' deep industry knowledge to support portfolio growth. The firm is known for its collaborative investment model and its ability to provide seed and early-stage funding to innovative healthcare technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seraph Capital.